P25. In vitro evaluation of the anticancer activity of ganetespib in combination with standard chemotherapeutics in small cell lung cancer (SCLC) cell lines

Documenti analoghi

• In vitro Cytotoxic Activities of the Oral Platinum(IV) Prodrug Oxoplatin and HSP90 Inhibitor Ganetespib against a Panel of Gastric Cancer Cell Lines
  di: Klameth, Lukas, et al.
  Pubblicazione: (2017)
• Anticancer Activity of Fascaplysin against Lung Cancer Cell and Small Cell Lung Cancer Circulating Tumor Cell Lines
  di: Rath, Barbara, et al.
  Pubblicazione: (2018)
• Expression of Proteolytic Enzymes by Small Cell Lung Cancer Circulating Tumor Cell Lines
  di: Rath, Barbara, et al.
  Pubblicazione: (2019)
• Effects of salinomycin and niclosamide on small cell lung cancer and small cell lung cancer circulating tumor cell lines
  di: Hochmair, Maximilian, et al.
  Pubblicazione: (2019)
• Second-line therapy for small cell lung cancer: exploring the potential role of circulating tumor cells
  di: Hamilton, Gerhard, et al.
  Pubblicazione: (2016)